- Home
- SFBC vs TCRX Comparison
SFBC vs TCRX Comparison
Compare SFBC & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFBC
- TCRX
- Stock Information
- Founded
- SFBC 1953
- TCRX 2018
- Country
- SFBC United States
- TCRX United States
- Employees
- SFBC N/A
- TCRX N/A
- Industry
- SFBC Savings Institutions
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- SFBC Finance
- TCRX Health Care
- Exchange
- SFBC Nasdaq
- TCRX Nasdaq
- Market Cap
- SFBC 108.3M
- TCRX 91.7M
- IPO Year
- SFBC N/A
- TCRX 2021
- Fundamental
- Price
- SFBC $45.96
- TCRX $1.72
- Analyst Decision
- SFBC
- TCRX Strong Buy
- Analyst Count
- SFBC 0
- TCRX 5
- Target Price
- SFBC N/A
- TCRX $9.40
- AVG Volume (30 Days)
- SFBC 4.1K
- TCRX 221.0K
- Earning Date
- SFBC 10-29-2025
- TCRX 11-11-2025
- Dividend Yield
- SFBC 1.68%
- TCRX N/A
- EPS Growth
- SFBC 59.31
- TCRX N/A
- EPS
- SFBC 2.43
- TCRX N/A
- Revenue
- SFBC $38,045,000.00
- TCRX $6,961,000.00
- Revenue This Year
- SFBC N/A
- TCRX $255.18
- Revenue Next Year
- SFBC N/A
- TCRX N/A
- P/E Ratio
- SFBC $18.67
- TCRX N/A
- Revenue Growth
- SFBC 8.26
- TCRX N/A
- 52 Week Low
- SFBC $44.00
- TCRX $1.02
- 52 Week High
- SFBC $55.85
- TCRX $6.23
- Technical
- Relative Strength Index (RSI)
- SFBC 44.22
- TCRX 46.23
- Support Level
- SFBC $45.23
- TCRX $1.60
- Resistance Level
- SFBC $46.56
- TCRX $1.74
- Average True Range (ATR)
- SFBC 0.51
- TCRX 0.11
- MACD
- SFBC -0.21
- TCRX -0.02
- Stochastic Oscillator
- SFBC 31.82
- TCRX 33.33
About SFBC Sound Financial Bancorp Inc.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.